UnitedHealth Group Incorporated $UNH Shares Sold by Heartland Bank & Trust Co

Heartland Bank & Trust Co lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,667 shares of the healthcare conglomerate’s stock after selling 100 shares during the quarter. Heartland Bank & Trust Co’s holdings in UnitedHealth Group were worth $1,144,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Citizens National Bank Trust Department increased its stake in shares of UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares during the period. Caitlin John LLC boosted its holdings in UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after buying an additional 111 shares in the last quarter. Triumph Capital Management purchased a new position in UnitedHealth Group during the second quarter valued at $1,324,000. Wealth Effects LLC lifted its holdings in UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares in the last quarter. Finally, Arlington Partners LLC purchased a new position in UnitedHealth Group during the second quarter valued at $2,229,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.2%

NYSE UNH opened at $358.80 on Tuesday. The firm has a 50 day simple moving average of $320.57 and a 200-day simple moving average of $346.99. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The firm has a market cap of $324.96 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 2.29 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the previous year, the business posted $6.80 EPS. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

Several research firms have issued reports on UNH. Mizuho increased their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday, October 8th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Finally, Morgan Stanley lifted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.